Cannabis Poland S.A.

zł 0.18As of Sun 8 Nov 2026, 12:00 UTC
WSE:CBDHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR 4.52%
Div yield —
ROE (163.82%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.42
PE TTM —
TSR TTM (20.74%)
Mkt cap zł 13.39M
ROIC (80.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 0.182
1.36%
(19.35%)
Hold 5|0|1|4|9
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
—
—
—
—
25.97%
30.27%
35.57%
21.53%
Revenuezł M
1.231
1.302
1.329
1.372
7.86%
9.05%
10.43%
12.55%
Peers (US$3.380M)
Cap (US$)
PE
11.79M
9.105x
3.756M
—
Capital
TTM
5Y
10Y
Leveragex
0.649
(0.027)
(0.027)
EBIT/Intx
0.669
0.113
0.110
Own earn%
135.31
6.97
9.11
Sh yield%
54.75
25.87
28.00
Owners
Insiders/Inst%
14.93
64.07
Short interest%
1.14
SBC / revenue%
0.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
28–35
$1 testx
0.9
Incr. ROIC%
104